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The transcription factor Sox1 is the earliest and most specific
known marker for mammalian neural progenitors. During fetal
development, Sox1 is expressed by proliferating progenitor cells
throughout the central nervous system and in no tissue but the
lens. We generated a reporter mouse line in which egfp is inserted
into the Sox1 locus. Sox1GFP animals faithfully recapitulate the
expression of the endogenous gene. We have used the GFP
reporter to purify neuroepithelial cells by fluorescence-activated
cell sorting from embryonic day 10.5 embryos. RNAs prepared from
Sox1GFP and Sox1GFP embryo cells were then used to perform a
pilot screen of subtracted cDNAs prepared from differentiating
embryonic stem cells and arrayed on a glass chip. Fifteen unique
differentially expressed genes were identified, all previously as-
sociated with fetal or adult neural tissue. Whole mount in situ
hybridization against two genes of previously unknown embry-
onic expression, Lrrn1 and Musashi2, confirmed the selectivity of
this screen for early neuroectodermal markers.
Neural stem cells are promising candidates for the developmentof cellular and genetic therapies for neurodegenerative disor-
ders such as Parkinson’s disease and Huntington’s disease (1), and
for creation of in vitro drug discovery and toxicological screens (2).
However, the biomedical application of neural stem cells will
require the generation of large homogenous populations of these
cells in vitro. One source of neural stem cells is embryonic stem (ES)
cells (3). ES cells are derived from the inner cell mass of the
preimplantation blastocyst-stage embryo and can be propagated
indefinitely in an undifferentiated, pluripotent state (4). The for-
mation of multicellular aggregates called embryoid bodies permits
the commitment of pluripotent ES cells into multiple cellular
lineages in vitro (5), mimicking aspects of cellular differentiation in
early embryos (6). This provides a powerful system for the discovery
of genes induced early during development and for functional
validation of candidate genes (7). A favored protocol for the
commitment of ES into neural lineage is the treatment of embryoid
bodies with all-trans retinoic acid (8–10). After induction and
outgrowth onto an adhesive substratum, up to 50% of cells express
the neural precursor markers Sox1 and Sox2 and can generate
neurons and glia (11).
Key advances in defining the optimal conditions for generating
and propagating neural stem cells are likely to come from a
proper understanding of the molecular mechanisms controlling
the fate decisions of pluripotent cells and of fetal and ES
cell-derived neural precursors. Here we describe a refined
approach to identify genes induced during neural specification
andor maintained in neural progenitor cells in vivo and in vitro.
Transgenic mice (Sox1GFP) were generated in which the en-
hanced GFP (egfp) reporter is inserted into the Sox1 gene via
gene targeting (12). Sox1 is the earliest specific marker of neural
precursors in the mouse embryo (13). It is present in prolifer-
ating neural precursors from the neural plate stage onwards. The
only other site of expression in the mid-gestation fetus is the lens
(Fig. 1A). Exit from mitosis and neuronal or glial differentiation
is accompanied by down-regulation of Sox1 (14). The GFP
knock-in allows the visualization of Sox1 expression in these
animals by fluorescence microscopy, and the purification of
Sox1-positive cells by f luorescence-activated cell sorting
(FACS). This purification allows preparation of RNAs for highly
selective differential screening of microarrays. We have tested
this approach by application to a custom microarray of a
subtractive cDNA population prepared from retinoic acid-
induced embryoid bodies.
Materials and Methods
Gene Targeting. A phage genomic DNA library from 129Ola
strain mouse was screened with a 2-kb probe containing the Sox1
ORF (generously provided by Larysa Pevny). From a resulting
phage containing 12 kb of Sox1 genomic sequence, 5.5- and
2.5-kb fragments flanking the Sox1 ORF were taken as 5 and 3
homology arms to prepare a targeting vector. The gene for egfp
was fused in-frame into the second of three consecutive ATGs
at the Sox1 translation initiation site (15, 16) via PCR. The fusion
product, linked via an internal ribosome entry site (IRES) (17)
to the gene encoding puromycin acetyltransferase (pac), was
cloned between the homology arms. A cytomegalovirus promot-
er-driven hygromycinR-thymidine kinase dual selection cassette
(18) flanked by loxP sites was inserted downstream of the
GFPirespac cassette (Fig. 1 A). After electroporation in E14Tg2a
ES cells and selection in hygromycin, three targeted clones were
identified by Southern analysis with flanking 5 and 3 probes,
and unique integration was confirmed for two of these by using
an egfp probe. Transient transfection with a Cre recombinase
expression vector was used to remove the selection cassette.
Clones that had undergone excision were selected for in the
presence of ganciclovir and screened by Southern analysis (Fig.
1B). One such clone (46C) was injected into blastocysts and
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passed through the germ line of chimeras to generate the
Sox1GFP mouse line. Mice were maintained on a mixed 129xMF1
background by breeding of heterozygotes to outbred MF1 mice.
Tissue Preparation. For analysis of Sox1GFP expression, heterozy-
gous Sox1GFP males were crossed with wild-type females. Midday
after vaginal plug was considered as embryonic day 0.5 (E0.5).
Females were killed by cervical dislocation, and the embryos
were dissected free of the uterus, washed in PBS, and observed
under a fluorescence microscope. For cryosectioning, embryos
were fixed in 4% paraformaldehyde (PFA), cryoprotected in
30% sucrose in PBS, and embedded in OCT compound before
cryosectioning at 10–12 m. Adult (4–7 weeks old) heterozy-
gous brains were dissected out and fixed in 4% PFA before
embedding in 2% agarose in PBS and sectioning at 50 m by
using a vibratome. Sections were counterstained with propidium
iodide and analyzed by confocal microscopy.
FACS Purification and RNA Preparation. E10.5 Sox1–GFP-positive
embryos were dissected free of extraembryonic membranes,
digested in 0.1% trypsin, and resuspended in cold 10% FCS in
PBS. The cells were sorted by flow cytometry to give two cell
populations, Sox1–GFP-positive (Sox1GFP) cells and Sox1–
GFP-negative (Sox1GFP) cells. The sample was kept cold at all
times to minimize RNA degradation and cell death during
sorting. Viable cells were gated by their forward and side scatter
characteristics, and gates were set to sort positive and negative
cell populations.
Total RNA was extracted from both cell populations by using
the RNeasy Minikit (Qiagen, Valencia, CA), according to the
manufacturer’s instructions. RNA yield was determined by
measuring absorbance at 260 nm. RNA quality was assessed by
electrophoresis of 1 g of RNA on a standard 1.2% formalde-
hyde agarose gel.
RT-PCR. To eliminate contaminating genomic DNA, 1 g of total
RNA was treated with 1 unit of DNase I (GIBCOBRL) for 15
min at 25°C. DNase I was inactivated with 25 mM EDTA (pH
8.0, GIBCOBRL) at 65°C for 10 min and chilled on ice. First
strand random-primed cDNA was synthesized by using Super-
script II Preamplification System (GIBCOBRL) as described
by the supplier. The cDNA was analyzed by PCR amplification
using individual primer pairs for specific marker genes. The PCR
cycling sequence used was 94.0°C for 3 min, followed by 20–35
cycles of 94.0°C for 30 s, 58.0–60.0°C for 30 s and 72.0°C for 1
min. This was followed by a final extension time of 7 min. All
PCR samples were analyzed by electrophoresis on 2% agarose
gels stained with ethidium bromide.
Microarray and Sequence Analysis. A subtracted library enriched
for genes expressed during retinoic acid-induced neural com-
mitment of ES cells (7) was spread out on LB plates containing
ampicillin and 5-bromo-4-chloro-3-indolyl -D-galactoside (X-
gal). A total of 384 white bacterial colonies were randomly
picked and cultured in 96-well plates. One microliter of each
bacterial culture was amplified by using the Advantage cDNA
PCR kit (CLONTECH) and PCR primers that are homologous
to the flanking regions of the cDNA insert (30–35 cycles: 30 s at
95°C, followed by 3 min at 68°C). PCR fragments were analyzed
by electrophoresis on 2% agarose gel. The average insert size was
between 200 and 800 bp. PCR products were printed onto
poly(lysine)-coated glass slides by using an Affymetrix (Santa
Clara, CA) 417 arrayer. Each cDNA insert was spotted in
triplicate. A collection of marker genes (see Fig. 2B) whose
expression was predetermined by RT-PCR analysis was included
to act as control for the specificity of neural expression in the
sorted Sox1 RNA populations.
Twenty micrograms of Sox1 or Sox1 total RNA obtained
from disaggregated embryos was reverse transcribed with Su-
Fig. 1. Targeting Sox1 and Sox1GFP expression. (A) In situ hybridization of an E10.5 embryo with a Sox1 riboprobe, showing expression restricted to and
throughout the neuraxis. (B) Schematic showing the design of the targeting vector and the screening strategy for identification of correctly targeted clones. (C)
Southern blots showing the correct targeting events and the excision of the cytomegalovirus (CMV) HyTK cassette after transient transfection with a Cre
expression plasmid. (Top) 5 probe. (Middle) Internal EGFP probe. (Bottom) 3 probe. Clone 14 is correctly targeted but has multiple integrations; clones 46 and
53 are correctly targeted, single integration clones. Clone 46C is a derivative of clone 46 after Cre-mediated deletion of the CMV Hy-TK cassette. Control is DNA
from the parental E14Tg2a ES cells. (D) Sox1GFP expression in embryos and adult animals. (i) Sox1GFP embryo at E9.5 showing expression throughout the length
of the neural tube. (ii) Dorsal anterior view of a Sox1GFP embryo at E11.5 showing exclusion of GFP fluorescence from the midline, indicating no expression in
roofplate and floorplate. (iii) Coronal section through the head of an E12.5 embryo showing Sox1GFP expression in the ventricular and subventricular zone and
the lens. (iv) Section through an adult Sox1GFP mouse brain, showing Sox1GFP-expressing cells in the subgranular layer of the hippocampus. (Inset) Higher
magnification of boxed area, showing a GFP-expressing cell in the granular layer.
Aubert et al. PNAS  September 30, 2003  vol. 100  suppl. 1  11837
perscript II (GIBCOBRL) in the presence of Cy3 dCTP after
priming with poly(dT) according to methods described by Brown
et al. (http:brownlab.stanford.edu). Cy3-labeled Sox1 and
Sox1 cDNA was hybridized (19, 20) to separate microarrays.
Scanning was performed with an Affymetrix 428 scanner, and
the program QUANTARRAY (Perkin–Elmer) was used for image
analysis. Multiple scans were taken to define the optimal dy-
namic range of signal for subsequent analysis. The background
was first subtracted for each respective probe element on the
array. The median value for the triplicate probe elements
representing each gene or insert was then defined. A scaling
factor was applied to the arrays representing normalization to
the 75th percentile of the global signal distribution. Ratios of
expression were then calculated by using these normalized
median values. A ratio value (Sox1Sox1) of 1.5 or greater
was used for the selection of neural specific expression.
Clones encoding 15 up-regulated transcripts (Table 1) were
sequenced, and the corresponding genes were identified by
BLASTN searches of nonredundant (nr), dbEST, and mouse
genomic databases. Protein domains were identified by using
SMART.
In Situ Hybridization. Subtracted library clones were used to
generate antisense RNA probes labeled with digoxygenin-UTP.
Automated in situ detection was carried out on E8.5, E10.5, and
E11.5 outbred mouse embryos by using an InsituPro machine
(Abimed, Langenfeld, Germany).
Results and Discussion
Expression of Sox1GFP. In undifferentiated ES cells in vitro there is
no detectable activity of the Sox1GFP allele but expression is
specifically activated on induction of neural differentiation as
described elsewhere (12, 14). In vivo after germ-line transmis-
sion, the GFP reporter is faithfully expressed in the nervous
system and lens, with no apparent ectopic expression. Sox1GFP
fluorescence is first detected around E8.5 throughout the neural
plate and headfolds (ref. 12 and data not shown). This is slightly
Fig. 2. FACS purification of neural precursors. (A) FACS profile showing cell
sorting of the Sox1 neural precursor population from the Sox1 cell popu-
lation from E10.5 mouse embryos. (B) Positive (R2, 30.35%) and negative (R1,
44.02%) populations were sorted and analyzed by RT-PCR for marker gene
expression.
Table 1. Genes identified by microarray analysis
Clone
Fold
increase
GenBank
accession
no. Gene symbol (synonyms), name Expression Domains
P5C3 2.40 CB968102 Nhlh2 (Hen2, Nscl-2, NSCL2), nescient helix–loop–helix 2 Dev NS and PN cerebellum HLH
P2H5 2.40 CB968096 Mm.156164 Dev and mature NS, epididymis
P2C5 1.98 CB968093 Khdrbs3 (SLM-2, Etle, T-STAR), KH domain containing,
RNA binding, signal transduction associated 3
Ad B and S muscletestes KH
P3B7 1.96 CB968098 Slc2a1 (Glut-1), solute carrier family 2 (facilitated
glucose transporter), member 1
E10 NT, OV, heart and gut TM
P5C11 1.96 CB968101 sFRP2 (Sdf5), secreted frizzled-related sequence
protein 2
E neuroepithelium CRD
P5H8 1.96 CB968107 Lrrn1 (NLRR-1), leucine-rich repeat protein 1, neuronal Dev CNS, DRG and cartilage LRRTM
P3C1 1.95 CB968099 Sox4, SRY-box-containing gene 4 Dev CNS, thymus, BM HMG
P3B1 1.94 CB968097 Zic1, zinc finger protein of the cerebellum 1 E cerebellum and dorsal 12
of NT
ZnF
P2E5 1.81 CB968094 Vim, vimentin Radial glia in Dev hindbrain CC
P5G9 1.76 CB968105 Rtn1, reticulon 1 Dev and mature NS TM
P5D11 1.69 CB968103 Msi2h (msi2), musashi homolog 2* Dev and mature NS, ubiquitous
by NB
RRM
P5D5 1.65 CB968104 Sox11, SRY-box-containing gene 11* Dev NS, sites of Ep–Mes
interactions
HMG
P5H2 1.63 CB968106 Qk, Quaking Myelin-forming cells KH
P5A9 1.60 CB968100 Hrmt1l3, HMT1 hnRNP methyltransferase-like 3* Dev and mature NS —
P2E7 1.51 CB968095 Tuba1 (Talpha1), tubulin 1 NPCs —
Data are fold increase in expression, accession number of each clone sequence, gene symbolsnames, characterized expression pattern, and protein domain
information (given where known). Ad, adult; B, brain; BM, bone marrow; CC, coiled coil; CRD, cysteine-rich domain; Dev, developing; DRG, dorsal root ganglia;
E, embryo; Ep, epithelial; HLH, helix–loop–helix; HMG, high-mobility group; KH, K homology RNA-binding domain; LRR, leucine-rich repeat; M, muscle; Mes,
mesenchymal; NB, Northern blot; NPCs, neural precursor cells; NS, nervous system; NT, neural tube; OV, optic vesicle; PN, postnatal; RRM, RNA recognition motif;
S, skeletal; TM, transmembrane; ZnF, zinc finger.
*The predicted transcripts from these genes are available in the Third Party Annotation Section of the DDBJEMBLGenBank databases under the accession
numbers TPA: BK001349, BK001483, and BK001484.
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later than the reported onset of expression of Sox1 mRNA and
protein (13, 14), presumably because of the time required for
correct folding and accumulation of GFP to detectable levels. At
E9.5 Sox1GFP is expressed along the entire neuraxis but in no
other tissue (Fig. 1Di). At mid-gestation, Sox1GFP is maintained
throughout the brain and the neural tube but is excluded from
the roofplate and floorplate (Fig. 1Dii). At this stage, Sox1GFP
expression also becomes evident in the lens where Sox1 has been
shown to regulate the -crystallin genes and to be necessary for
lens fiber cell elongation (21). The distribution of Sox1GFP is in
agreement with the published expression of Sox1 mRNA and
protein (14). In later stages of embryonic development, Sox1GFP
is excluded from most differentiated neurons and glia but is
maintained in the proliferative ventricular zone and in the lens
(Fig. 1Diii).
In the brains of adult animals Sox1GFP is prominently ex-
pressed in the subgranular layer of the dentate gyrus (Fig. 1Div).
Numerous GFP-expressing cells are seen in the inner subgranu-
lar layer, the area where adult neural progenitors have been
shown to reside (22). Neurons born in this area subsequently
migrate through the granular layer of the dentate gyrus. At
higher magnification, smaller numbers of GFP-positive cells can
be observed in the granular layer in Sox1GFP mice.
Heterozygous Sox1GFP animals are viable and apparently healthy
with no obvious phenotype. Homozygous null Sox1GFP mice have
small eyes with opaque lenses and suffer from spontaneous sei-
zures, as described for Sox1 mutants (21).
FACS Purification and RNA Probe Generation. E10.5 Sox1GFP em-
bryos were trypsinised, and the resultant pool of cells was sorted
by flow cytometry based on GFP expression. Cell sorting yielded
a Sox1GFP neural precursor population (gate R1) and a
Sox1GFP control population (gate R2) (Fig. 2 A). RNA was
extracted from the Sox1 and Sox1 cells. To confirm the
identity of the two RNA populations, cDNA was produced by
reverse transcription and analyzed by RT-PCR. We examined
the presence in both populations of a number of known genes
whose expression pattern is both spatially and temporally de-
fined during development (Fig. 2B).
As expected, Sox1 mRNA was restricted to Sox1GFP cells.
Genes known to be restricted to neural progenitors populations
such as Ngn2 and Pax6 (23) displayed a similar restriction to the
GFP population. Pax7, Nestin, and sFRP2 all show strong
expression in the GFP population but are also represented in
the GFP fraction. This is in agreement with a predominant
expression of these genes in the developing CNS with additional
expression in the somitic mesoderm (Nestin and Pax7) and in the
mesonephros (sFRP2) (23–25). RT-PCR analysis revealed weak
expression of the ShcC gene in the Sox1 cell population. ShcC
is an adapter protein that is predominantly expressed in mature
neurons (26, 27). As neurogenesis in the neural tube begins at
E9.5, the expression seen here could be indicative of a small
number of early neurons present in the Sox1 cell population.
This could arise from perdurance of GFP after differentiation
and Sox1 down-regulation.
RNAs for bone morphogenic protein 4 (BMP4), a marker for
early mesodermal differentiation (28), and Sox10, a key regu-
lator in the differentiation of peripheral glial cells, with high
expression in neural crest cells and cells of the melanocyte
lineage, were preferentially expressed in Sox1GFP cells. To-
gether, these results confirm the efficient separation of neural
and nonneural cell populations by flow cytometry.
P311 and Riken cDNA 2810027O19 represent two genes that are
induced in retinoic acid treated embryoid bodies (7). These genes
show similar expression levels in Sox1 and Sox1 cell popula-
tions. This result is consistent with the expression profile revealed
by in situ hybridization analyses. Both mRNAs are abundant in the
neural tube, but P311 is also found in the somites and apical
ectodermal ridge (7) and Riken cDNA 2810027O19 mRNA is
present in migrating neural crest cells, the apical ectodermal ridge,
and in condensing mesenchymal cells (data not shown). These two
examples illustrate a limitation in the selectivity of screens based on
total cell populations from retinoic acid-induced differentiating
embryoid bodies (see below).
Microarray Analysis. We have previously generated a subtracted
library enriched for genes induced during retinoic acid-induced
differentiation of ES cells (7). Analysis by differential filter
hybridization indicated substantial enrichment for genes of
interest. Of 480 clones, 138 (29%) were preferentially expressed
during retinoic acid-mediated differentiation. These corre-
sponded to 96 unique genes, 40% of which showed enriched
expression in the developing or adult CNS (7). However, most of
these clones also showed appreciable expression in nonneural
tissues of the developing fetus as exemplified by P311 and Riken
cDNA 2810027O19. We reasoned that a more stringent screen
of the SSH library would be to perform the differential hybrid-
ization with Sox1GFP-purified cell populations from embryos
rather than whole cell populations from embryoid bodies.
To test this idea, we generated a cDNA microarray from 384
randomly picked clones from the SSH library and carried out a
differential hybridization screen with RNAs generated from the
Sox1GFP embryos. Also included on the array were a number of
the marker genes used for characterization of the Sox1 GFP
RNA isolated from embryos (Fig. 2).
The Sox1 and Sox1 RNA samples were labeled and
hybridized to the array. The majority of the marker genes shown
to be preferentially expressed in Sox1 RNA by RT-PCR
analysis (e.g., Sox1, Ngn2, Nestin, and Pax6; Fig. 2B) showed
expression fold changes of 1.5 when analyzed by microarray
analysis. The expression of Sox10, P311, and the motor neuron
precursor marker Islet1 was not elevated in the Sox1 popula-
tion, consistent with additional sites of expression in ventral
mesoderm and endoderm (29). The expression of these marker
genes determined by the microarray screen is in a broad agree-
ment with the RT-PCR profiles of the sorted RNA populations
and known expression within and outwith the embryonic CNS.
Clone Identification. Fifteen clones that demonstrated the highest
differential Sox1Sox1 expression ratios (1.5) were taken
for sequencing. Fourteen sequences correspond to known genes,
all of which had previously been associated with either devel-
oping or adult CNS (Table 1). Clones P5D11 (Msi2h) and P5D5
(Sox11) do not match known genes directly but are derived from
extended 3UTR regions that lie downstream of the current gene
annotation. In each case, the sequence can be linked to the
identified gene via a contiguous assembly of expressed se-
quences. The discovery of additional 3 UTR sequences is
consistent with the fact that a Musashi2 (Msi2h) 3 UTR probe
detects a 7.1-kb transcript and suggests that the original 2.3-kb
Msi2h cDNA sequence (AB056103) is incomplete (30). We also
noted that the first 513 base pairs of the original Msi2h cDNA
sequence do not align with other Msi2h ESTs or the human MSI2
sequence. In fact, this presumed 5 UTR sequence has a 100%
match with a genomic sequence on mouse chromosome 1,
suggesting that the original cDNA is a hybrid of two clones.
Msi2h is thought to play a role in the maintenance and prolif-
eration of CNS precursor cells (30, 31).
The relationship between clone P5D5 and Sox11 was detected
by combining sequences from two unigene clusters Mm.41704
and Mm.254253 into a single contiguous sequence of7 kb. This
relatively long predicted transcript is consistent with human
SOX11, which has a 3 UTR of 8 kb (32). Interestingly, the
screen identified a second SRY-box-containing gene, Sox4,
which is expressed in the differentiating subventricular zone
progenitors during neurogenesis (33) and has a role during B cell
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differentiation and heart development (34). Sox4 and Sox11
encode class C Sox proteins, are closely related at the sequence
level, and have similar expression pattern. It has been proposed
that they may be functionally redundant during CNS develop-
ment (33).
Hrmt1l3 (clone P5A9) has not been described in mouse, but is
presumed to be the orthologue of human hnRNP methyltrans-
ferase-like 3 (HRMT1L3)-based high identity (99%) and
conserved synteny. The gene encoding P2H5 remains to be
identified; this sequence matches a unigene cluster containing
ESTs that are derived exclusively from neural tissues and have
moderate similarity to Neural Wiskott–Aldrich syndrome pro-
tein (N-WASP).
The remaining up-regulated genes were identified as being
expressed predominantly in developing or adult nervous system.
The identification of Reticulon 1, an endoplasmic reticulum
protein of unknown function, in this screen is consistent with the
fact that this protein is localized in neuroepithelial progenitors
at the pallio-subpallial boundary of the developing telencepha-
lon (35).
The gene for the intermediate filament protein, vimentin,
which is expressed in radial glia (36), was up-regulated in the
Sox1 fraction. Radial glia are thought to serve as precursor
cells in the developing forebrain (37). The neuronal precursor
cell marker tubulin 1 (38) was also enriched in Sox1 cells.
Nescient helix–loop–helix 2 (Nhlh2) is a basic helix–loop–helix
transcription factor that is reported to be transiently expressed
in subependymal cells throughout the CNS at mid-gestation and
also transiently in the postnatal cerebellum (39, 40). Expression
in the Sox1 fraction could reflect the perdurance of GFP or an
earlier onset of Nhlh2 expression than previously described.
sFRP2, encoding the Wnt antagonist secreted frizzled-related
protein-2, is expressed in the embryonic neuroepithelium (25,
41). This gene was also isolated in the previous screen of this
library and demonstrated to promote neural differentiation of
ES cells (7). Detection of sFRP2 in the microarray screen
demonstrates the potential of this approach for identification of
functionally significant players in neural differentiation.
The KH domain containing, RNA binding, signal transduc-
tion-associated 3 (Khdrbs3) gene is a predominantly nuclear
RNA-binding protein which heterodimerizes with Sam68 (68-
kDa Src substrate associated during mitosis). Khdrbs3 expression
has been observed in adult brain and also skeletal muscle (42).
Its embryonic expression and functional role have yet to be
defined.
Expression of Lrrn1 (leucine-rich repeat protein 1, neuronal)
has been reported in the CNS at E11.5 by Northern-blot, and
whole mount in situ hybridization on E13.5 revealed a predom-
inant expression in the developing nervous system (43). Al-
though its role remains unknown, the LRR domain is proposed
to function in cell adhesion and has been implicated in a variety
of events in neural development.
In Situ Hybridization. We used whole mount in situ hybridization
to examine the embryonic expression of two genes emerging
from the microarray screen, Lrrn1 and Msi2h. Both have been
suggested to play significant roles in neural development (Fig. 3).
At E8.5, Msi2h hybridization is readily detected in the hindbrain
and the otic vesicle, and is not evident in any other tissue. Lrrn1
mRNA is detectable along the entire antero-posterior axis of the
neuroectoderm, with additional faint expression in somites. At
E10.5, Msi2h expression is maintained in the hindbrain and otic
vesicle, but also extends along the neural tube. Hybridization is
also apparent in dorsal root ganglia and limb bud (Fig. 3D).
Lrrn1 mRNA on E10.5 is present in the ventral-most neural tube
as well as the hindbrain and the telencephalic vesicle, and is also
prominent in the somites.
Conclusion
In this study, we have shown that Sox1–gfp knock-in mice allow
reliable visualization and purification of pan-neural progenitor
cells from mid-gestation mouse embryos. Importantly, Sox1 is
expressed in neuroepithelial cells throughout the entire neuraxis,
labeling all categories of regionally specified neural precursor.
The particular advantage of Sox1 over the other well established
pan-neural marker nestin is that there is no detectable expres-
sion outwith the CNS during early to mid-fetal development
apart from in the well defined structure of the lens. Examination
in whole mount embryos shows that the Sox1GFP reporter
reproduces faithfully the expression of Sox1. Interestingly, pre-
liminary analyses of adult brains have highlighted expression in
the subgranular layer of the dentate gyrus (Fig. 1), a region for
which there is now overwhelming evidence of the persistence of
neural precursor cells (22, 44). Thus, Sox1GFP may be a useful
marker of adult neural precursors. Further studies are required
to test this directly.
In the present study, we used FACS to separate Sox1-GFP-
positive and -negative populations from whole E10.5 mouse
embryos. Analysis of a panel of markers by RT-PCR yielded
expression data consistent with the substantial elimination of
nonneural cells from the GFP-positive population and con-
versely the absence of neural precursors from the GFP-negative
population.
We then carried out a pilot microarray screen with the aim of
identifying genes specifically expressed both during neural com-
mitment of ES cells and in neural progenitor cells in vivo. From
384 arrayed SSH clones, we identified 15 unique clones showing
preferential expression in the GFP-positive cell population. Of
these, 11 represent known genes previously reported as ex-
pressed in embryonic andor adult neural tissues, particularly in
the brain. The remaining genes were ESTs, each of which has
originated from libraries derived from neural tissues. We have
been able to identify three of the ESTs as corresponding to
Musashi2, Sox11, and Hrmt1l3. Musashi2 has previously been
described as ubiquitously expressed based on Northern analyses
Fig. 3. Expression of Lrrn1 and Musashi2 mRNAs in mouse embryos. (A)
Lateral view of E8.5 embryo showing Msi2h hybridization in the hindbrain and
the otic vesicle. (B and C) Lateral and dorsal view, respectively, of an E10.5
embryo showing Msi2h hybridization in the neural tube, hindbrain, and otic
vesicles. (D) Transverse section at E11.5 showing specific Msi2h hybridization
in the ventral half of the neural tube and the dorsal root ganglia. (E) Lateral
view of an E8.5 embryo showing Lrrn1 hybridization in the neural tube and
weakly in the somites. (F and G) Lateral and dorsal view, respectively, of an
E10.5 embryo showing Lrrn1 hybridization in the telencephalic vesicle, the
hindbrain, the otic vesicle, and the somites. (H) Transverse section at E10.5
shows Lrrn1 hybridization in the ventral part of the neural tube and the
somites.
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of adult tissues (30). However, our in situ hybridization data show
that this gene is preferentially expressed in neural tissue in the
fetus. It is noteworthy that marker genes with expression in the
developing nervous system but substantial additional nonneural
expression (i.e., Sox10, Islet1, P311, and Riken cDNA
2810027O19) were not significantly enriched in the Sox1
population. Furthermore, several clones were found to be
present at higher levels in the Sox1 RNA population (data not
shown). These clones most likely correspond to transcripts
expressed in nonneural tissues induced by retinoic acid treatment
of embryoid bodies.
The fold enrichment value is not an absolute measure of
differential expression, and in many cases may be a considerable
underestimate of the selectivity of expression caused by the
heterogeneity of the Sox1 population. Sox1 marks the entire
pool of proliferating precursors in the neural tube, whereas all
of the genes identified have a regionally restricted expression. A
previous study has indicated that complex tissues such as the
brain are prone to a ‘‘dilution effect’’ when analyzed by microar-
ray, yielding lower levels of fold change and smaller numbers of
differentially expressed genes compared with studies using cell
lines (45). Nonetheless, larger-scale screening may identify genes
with broader neural expression and consequent higher fold
enrichment values.
Overall, this study demonstrates the potential of combining in
vitro ES cell differentiation and in vivo lineage purification with
microarray technology to achieve rapid, efficient identification
of genes expressed selectively in tissues and stages of interest.
Previously described expression profiles and our in situ hybrid-
ization data of the differentially regulated clones examined
confirms the underlying principle of using RNA prepared from
Sox1-selected cells to screen custom-built microarrays enriched
for neural genes. This pilot scale screen has been sufficient to
highlight several genes, notably Nhlh2, Lrrn1, Hrmt1l3, Rtn1, and
the unknown gene corresponding to the P2H5 EST, for further
investigation as potential regulators of neural development. A
rapid means of assessing the significance of these genes would be
via episomal gain-of-function analyses in ES cells (7).
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